| # |
Date |
Topic (click for streaming
video) |
Chapter |
Professor |
| 1 |
Jan
10 |
Introduction;
Principles of Pharmacokinetics |
-- |
Galloway |
| 2 |
Jan
12 |
Basic
Principles of Neuropharmacology and Pharmacodynamics |
1 |
Galloway |
| 3 |
Jan
17 |
Neuronal
Cell Types: Interactions and Anatomy |
2 |
Galloway |
| 4
|
Jan
19 |
The
Membrane Potential |
2 |
Perrine |
| 5 |
Jan
24 |
The
Action Potential and its Molecular Basis |
2 |
Perrine |
| 6 |
Jan
26 |
Synaptic
Transmission |
3 |
Conti |
| 7 |
Jan
31 |
Signal
Transduction |
4 |
Granneman |
| 8 |
Feb
2 |
Nuclear
Signaling: Gene Expression |
4 |
Leff |
| Ex |
Feb
7 |
Exam
I |
- |
Galloway |
| 9 |
Feb
9 |
Neurotransmitters
I: Glutamate, GABA, Glycine |
5 |
Galloway |
| 10 |
Feb
14 |
Neurotransmitters
II: Catecholamines |
6 |
Galloway |
| 11 |
Feb
16 |
Neurotransmitters
III: Serotonin, Acetylcholine, Histamine |
6 (9) |
Galloway |
| 12 |
Feb
21 |
Neurotransmitters
IV: Peptides, CB, NO |
7,8 |
Perrine |
| 13 |
Feb
23 |
Neurotransmitters
V: Neurotrophic Factors |
8 (9) |
Granneman |
| 14 |
Feb
28 |
Neuroimaging
in Neuropsychiatric Research: PET, MR, SPECT |
-- |
Galloway |
| 15 |
Mar
1 |
Neurodegeneration:
Mechanisms |
17 |
Benjamins |
| 16 |
Mar
6 |
Neuroendocrine
Physiology |
10 (9) |
Mackenzie |
| 17 |
Mar
8 |
Pain
& Inflammation |
11 |
Galloway |
| 18 |
Mar 20
Tu |
Review
Session |
- |
Galloway |
| Ex |
Mar 22 Th |
Exam
II |
|
Galloway |
| 19 |
Mar
27 Tu |
Mood,
Bipolar, and Anxiety Disorders |
14 |
Galloway |
| 20 |
Mar
29 Th |
Sleep
and Arousal |
12 |
Galloway |
| 21 |
Ap 3 Tu |
Higher
Cognition: Schizophrenia |
16 |
Galloway |
| 22 |
Ap 5 Th |
Higher
Cognitive Function: Behavior, Memory, Alzheimer’s |
13, 17 |
Galloway |
| 23 |
Ap 10 Tu |
Reinforcement
I: Pathways and Mechanisms of Addiction |
15 |
Galloway |
| 24 |
Ap 12 Th |
Anesthesia |
(11,12) |
McKelvey |
| 25 |
Ap 17 Tu |
Movement
Disorders: Parkinson’s Disease, Huntington’s, ALS |
17 |
LeWitt |
| Rv |
Ap 19 Th |
Review |
|
Galloway |
| 26 |
Ap 24Th |
Stroke
and Seizure Disorders |
18,19 |
Loeb |
